NO180334C - Analogifremgangsmåte for fremstilling av terapeutisk aktive difluorstatonanaloger - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive difluorstatonanalogerInfo
- Publication number
- NO180334C NO180334C NO932377A NO932377A NO180334C NO 180334 C NO180334 C NO 180334C NO 932377 A NO932377 A NO 932377A NO 932377 A NO932377 A NO 932377A NO 180334 C NO180334 C NO 180334C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- analogs
- difluorostatone
- therapeutically active
- analogous process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91400005 | 1991-01-02 | ||
| PCT/US1991/009741 WO1992012123A1 (en) | 1991-01-02 | 1991-12-20 | Anti-viral compounds |
| US08/788,098 US5716973A (en) | 1991-01-02 | 1997-01-23 | Anti-viral compounds |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO932377D0 NO932377D0 (no) | 1993-06-29 |
| NO932377L NO932377L (no) | 1993-06-29 |
| NO180334B NO180334B (no) | 1996-12-23 |
| NO180334C true NO180334C (no) | 1997-04-02 |
Family
ID=26129945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO932377A NO180334C (no) | 1991-01-02 | 1993-06-29 | Analogifremgangsmåte for fremstilling av terapeutisk aktive difluorstatonanaloger |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5716973A (de) |
| EP (1) | EP0565631B1 (de) |
| JP (1) | JP3198416B2 (de) |
| AT (1) | ATE143025T1 (de) |
| AU (1) | AU649766B2 (de) |
| CA (1) | CA2098020C (de) |
| DE (1) | DE69122266T2 (de) |
| DK (1) | DK0565631T3 (de) |
| ES (1) | ES2094344T3 (de) |
| FI (1) | FI106466B (de) |
| GR (1) | GR3021988T3 (de) |
| HU (1) | HU210647B (de) |
| IE (1) | IE75381B1 (de) |
| IL (1) | IL100477A (de) |
| NO (1) | NO180334C (de) |
| NZ (1) | NZ241099A (de) |
| PT (1) | PT99961B (de) |
| WO (1) | WO1992012123A1 (de) |
| ZA (1) | ZA9110141B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071895A (en) * | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
| CA2130754C (en) * | 1992-03-11 | 2005-02-08 | Damian W. Grobelny | Amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
| US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
| ATE253050T1 (de) | 1992-03-11 | 2003-11-15 | Narhex Ltd | Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen |
| US5559256A (en) * | 1992-07-20 | 1996-09-24 | E. R. Squibb & Sons, Inc. | Aminediol protease inhibitors |
| US5939430A (en) * | 1993-02-22 | 1999-08-17 | Merrell Pharmaceuticals Inc. | Combinations of retroviral inhibitors |
| GB9303518D0 (en) * | 1993-02-22 | 1993-04-07 | Merrell Dow Pharma | Combinations of retroviral inhibitors |
| WO1995001958A1 (en) * | 1993-07-08 | 1995-01-19 | Merrell Pharmaceuticals Inc. | Difluoro statone analogs |
| NZ271825A (en) * | 1993-09-09 | 1997-11-24 | Merrell Pharma Inc | Difluoro statone derivatives, preparation and pharmaceutical compositions thereof |
| IL110898A0 (en) * | 1993-09-10 | 1994-11-28 | Narhex Australia Pty Ltd | Polar-substituted hydrocarbons |
| US5977074A (en) * | 1993-10-01 | 1999-11-02 | Merrell Pharmaceuticals, Inc. | Inhibitors of β-amyloid protein production |
| PT742791E (pt) * | 1994-02-04 | 2001-06-29 | Merrell Pharma Inc | Derivados de difluorostatona macrolitica uteis como agentes antivirais |
| CA2195125C (en) * | 1994-07-15 | 2003-12-16 | Robert A. Farr | Difluorostatone antiviral agents |
| US6114380A (en) * | 1995-12-18 | 2000-09-05 | Merrell Pharmaceuticals Inc. | Difluoro statone analogs |
| NZ530051A (en) | 2001-06-12 | 2006-12-22 | Wellstat Therapeutics Corp | Polycyclic oxy-aromatic acid derivatives for the treatment of metabolic disorders |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1171103A (en) * | 1966-03-24 | 1969-11-19 | Gas Council | Hydrogenation of Hydrocarbons. |
| US5066643A (en) * | 1985-02-19 | 1991-11-19 | Sandoz Ltd. | Fluorine and chlorine statine or statone containing peptides and method of use |
| CH672792A5 (de) * | 1985-02-19 | 1989-12-29 | Sandoz Ag | |
| WO1986006379A1 (en) * | 1985-04-19 | 1986-11-06 | The Upjohn Company | Dihalo-statine substituted renin inhibitors |
| GB8619182D0 (en) * | 1986-08-06 | 1986-09-17 | Sandoz Ltd | Peptides & derivatives |
| NZ223148A (en) * | 1987-01-16 | 1989-10-27 | Merrell Dow Pharma | Peptide derivatives having peptidase inhibition activity |
| FR2614533A1 (fr) * | 1987-04-23 | 1988-11-04 | Sandoz Sa | Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments |
| GB2212158A (en) * | 1987-12-15 | 1989-07-19 | Sandoz Ltd | Trialkylsilymethyl-substituted peptides; renin inhibitors |
| AU3964489A (en) * | 1988-07-08 | 1990-02-05 | Smithkline Beckman Corporation | Retroviral protease binding peptides |
| IL90872A0 (en) * | 1988-07-08 | 1990-02-09 | Smithkline Beckman Corp | Retroviral protease binding peptides |
| CA2010531A1 (en) * | 1989-03-06 | 1990-09-06 | Werner Neidhart | Amino acid derivatives |
| US5151438A (en) * | 1989-05-23 | 1992-09-29 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| KR100220876B1 (ko) * | 1991-01-02 | 1999-10-01 | 슈테펜엘.네스비트 | 항 바이러스 화합물 |
| WO1993019059A1 (en) * | 1992-03-25 | 1993-09-30 | Pfizer Limited | Antiviral peptides |
| EP0641325B1 (de) * | 1992-05-21 | 2001-03-07 | Monsanto Company | Inhibitoren retroviraler proteasen |
-
1991
- 1991-12-20 AT AT92904336T patent/ATE143025T1/de not_active IP Right Cessation
- 1991-12-20 WO PCT/US1991/009741 patent/WO1992012123A1/en active IP Right Grant
- 1991-12-20 JP JP50439692A patent/JP3198416B2/ja not_active Expired - Lifetime
- 1991-12-20 DK DK92904336.2T patent/DK0565631T3/da active
- 1991-12-20 DE DE69122266T patent/DE69122266T2/de not_active Expired - Lifetime
- 1991-12-20 HU HU9301918A patent/HU210647B/hu not_active IP Right Cessation
- 1991-12-20 NZ NZ241099A patent/NZ241099A/xx unknown
- 1991-12-20 EP EP92904336A patent/EP0565631B1/de not_active Expired - Lifetime
- 1991-12-20 ES ES92904336T patent/ES2094344T3/es not_active Expired - Lifetime
- 1991-12-20 AU AU91790/91A patent/AU649766B2/en not_active Ceased
- 1991-12-20 CA CA002098020A patent/CA2098020C/en not_active Expired - Fee Related
- 1991-12-23 IL IL10047791A patent/IL100477A/en not_active IP Right Cessation
- 1991-12-23 ZA ZA9110141A patent/ZA9110141B/xx unknown
- 1991-12-31 PT PT99961A patent/PT99961B/pt not_active IP Right Cessation
- 1991-12-31 IE IE458091A patent/IE75381B1/en not_active IP Right Cessation
-
1993
- 1993-06-29 FI FI932997A patent/FI106466B/fi active
- 1993-06-29 NO NO932377A patent/NO180334C/no not_active IP Right Cessation
-
1996
- 1996-12-11 GR GR960403424T patent/GR3021988T3/el unknown
-
1997
- 1997-01-23 US US08/788,098 patent/US5716973A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP3198416B2 (ja) | 2001-08-13 |
| FI932997A (fi) | 1993-06-29 |
| DE69122266D1 (de) | 1996-10-24 |
| CA2098020C (en) | 2003-10-21 |
| PT99961A (pt) | 1993-01-29 |
| HUT65739A (en) | 1994-07-28 |
| EP0565631B1 (de) | 1996-09-18 |
| AU9179091A (en) | 1992-08-17 |
| ATE143025T1 (de) | 1996-10-15 |
| CA2098020A1 (en) | 1992-07-03 |
| ZA9110141B (en) | 1992-10-28 |
| IE75381B1 (en) | 1997-09-10 |
| DK0565631T3 (da) | 1996-10-07 |
| NO932377D0 (no) | 1993-06-29 |
| WO1992012123A1 (en) | 1992-07-23 |
| PT99961B (pt) | 1999-06-30 |
| HU9301918D0 (en) | 1993-12-28 |
| IE914580A1 (en) | 1992-07-15 |
| EP0565631A1 (de) | 1993-10-20 |
| NO180334B (no) | 1996-12-23 |
| NO932377L (no) | 1993-06-29 |
| FI106466B (fi) | 2001-02-15 |
| DE69122266T2 (de) | 1997-03-27 |
| AU649766B2 (en) | 1994-06-02 |
| US5716973A (en) | 1998-02-10 |
| GR3021988T3 (en) | 1997-03-31 |
| ES2094344T3 (es) | 1997-01-16 |
| FI932997A0 (fi) | 1993-06-29 |
| HU210647B (en) | 1995-06-28 |
| JPH07502255A (ja) | 1995-03-09 |
| IL100477A (en) | 1996-07-23 |
| NZ241099A (en) | 1994-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO180334C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive difluorstatonanaloger | |
| NO168372C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykloforbindelser | |
| NZ208529A (en) | 2-pyrimidinyl-1-piperazine derivatives and pharmaceutical compositions | |
| NO20000762L (no) | Anvendelse av substituerte adeninderivater til behandling av multippel sklerose | |
| FI903571A0 (fi) | Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi | |
| NO179209C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte silylalkylenaminer | |
| FR2355846A1 (fr) | Esters de penicillines utilisables comme medicaments | |
| ES8202539A1 (es) | Procedimiento para la preparacion de nuevos derivados de prostaglandina | |
| ES2133573T3 (es) | Analogos antiviricos de difluoro estatone. | |
| ES2066605T3 (es) | Nuevas ureas y tioureas, su preparacion y su aplicacion en terapeutica. | |
| ES2152982T3 (es) | Analogos de la difluoroestatona. | |
| CA2249786A1 (en) | Difluoro statone analogs | |
| IT1263913B (it) | Composti terapeuticamente attivi, utili per il trattamento di malattieconnesse con alterata funzionalita' del sistema immunitario, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JUNE 2001 |